When the estimated wait for a donor kidney stretched from four years to five, and then from five to eight, C.J. Dabney started to fear that he would die before getting a transplant. So he didn't need convincing earlier this year when doctors offered a radical new alternative — a kidney infected with hepatitis C.
"I'm in," he said.
On Friday Dabney, 54, became the first patient in Minnesota to receive a kidney from a donor who was carrying the virus.
"Five years ago, this would have been impossible to do," said Dr. Jeffrey Wang, the nephrologist who recommended the procedure. The difference is new drug therapies that are curing what was previously a chronic infection, making the organs safe for transplant by healing the kidney's recipient.
Wang and transplant specialists at HCMC in Minneapolis said they hope the development can reduce waiting times that have sometimes amounted to a death sentence for patients with kidney failure. In Minnesota alone, 2,160 people are awaiting kidney transplants, and 704 have been waiting at least three years. Last year, 93 people on Minnesota's list died awaiting transplant, and another 74 were removed from the list because they had become too sick.
"This opens up a whole new group of donors," said Dr. Paul Stahler, who performed Dabney's transplant at HCMC.
The nation's opioid crisis, sadly, has increased the opportunity for organ procurement, Stahler said, because many overdose victims are young and have organs that are stronger and ideal for transplant. But many also suffered hepatitis C infections, often due to shared use of needles, that prevented organ donation until now.
While many screening criteria can rule out organs as unfit for transplant, hepatitis C has been a significant one because it is a leading cause of liver failure and transplants itself.